过度表达EZH2与攻击性行为有关,并促进中枢神经系统的细胞增殖,WHO 3级脑膜瘤
Péter Szőke1, Dániel Sztankovics1, Titanilla Dankó1
1Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Neuro-oncology advances
|July 28, 2025
概括
增强性肠道同源2 (EZH2) 促进了侵略性中枢神经系统 (CNS) 3级脑膜瘤的增殖. 用EPZ-6438抑制EZH2减少了瘤细胞的生长和增殖在体外和体内.
科学领域:
- 神经瘤学神经瘤学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
背景情况:
- 世界卫生组织 (WHO) 中枢神经系统 (CNS) 3级脑膜瘤是具有有限全身治疗选择的侵袭性瘤.
- 最近的研究表明,增加的增强性肠道同类素2 (EZH2) 表达与脑膜瘤等级相关.
- EZH2 是一种质甲基转移酶,涉及各种癌症.
研究的目的:
- 在3级脑膜瘤中描述EZH2表达的临床和分子相关物.
- 研究EZH2在3级脑膜瘤进展中的功能作用.
- 在临床前模型中评估EZH2抑制剂的疗效.
主要方法:
- 与临床结果数据相关的EZH2表达,49种3级脑膜瘤中的遗传变化 (p16,H3 K27me3,9p21.3删除,pTERT突变).
- 在实验室中研究了EZH2抑制剂EPZ-6438对IOMM-Lee人类3级脑膜瘤细胞系的影响.
- 在口服EPZ-6438后的老鼠异种移植模型中评估瘤生长抑制.
主要成果:
- 较高的EZH2过度表达与较短的存活率和3级脑膜瘤增多的增多相关.
- 9p21.3删除和H3 K27me3的损失与EZH2水平升高有关.
- 在实验室中,EPZ-6438抑制了细胞增殖,细胞循环进展,改变了基因表达 (p21,FOXM1),并在体内显示了适度的瘤生长抑制.
结论:
- EZH2在促进3级脑膜瘤细胞增殖方面发挥着功能性作用.
- EZH2可能是侵袭性脑膜瘤的治疗点.
- 向EZH2需要进一步研究,以便在中枢神经系统脑膜瘤中临床应用.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K


